Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000919574-13-006733
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-15 19:28:35
Reporting Period:
2013-11-14
Filing Date:
2013-11-15
Accepted Time:
2013-11-15 19:28:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278388 C Neal Bradsher C/o Broadwood Capital Inc.
724 Fifth Avenue, 9Th Floor
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-14 15,000 $0.90 19,183 No 4 M Direct
Common Stock Acquisiton 2013-11-14 25,000 $0.83 44,183 No 4 M Direct
Common Stock Disposition 2013-11-14 15,000 $62.31 29,183 No 4 S Direct
Common Stock Disposition 2013-11-14 25,000 $62.46 4,183 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares OPTION TO PURCHASE COMMON SHARES Disposition 2013-11-14 15,000 $0.00 15,000 $0.90
Common Shares OPTION TO PURCHASE COMMON SHARES Disposition 2013-11-14 25,000 $0.00 25,000 $0.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-03-25 No 4 M Direct
0 2014-03-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,796,660 Indirect Footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares OPTION TO PURCHASE COMMON SHARES $34.86 2023-05-24 9,203 9,203 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $40.37 2022-05-09 15,214 15,214 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $14.73 2020-12-31 17,500 17,500 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $14.73 2020-12-31 15,000 15,000 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $4.75 2019-12-31 17,500 17,500 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $4.75 2019-12-31 15,000 15,000 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $9.31 2018-12-31 32,500 32,500 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $5.77 2017-12-31 32,500 32,500 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $1.47 2016-12-31 32,500 32,500 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $1.04 2015-12-31 32,500 32,500 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $0.53 2014-12-31 32,500 32,500 Direct
Common Shares OPTION TO PURCHASE COMMON SHARES $0.84 2014-05-16 7,500 7,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2023-05-24 9,203 9,203 Direct
2022-05-09 15,214 15,214 Direct
2020-12-31 17,500 17,500 Direct
2020-12-31 15,000 15,000 Direct
2019-12-31 17,500 17,500 Direct
2019-12-31 15,000 15,000 Direct
2018-12-31 32,500 32,500 Direct
2017-12-31 32,500 32,500 Direct
2016-12-31 32,500 32,500 Direct
2015-12-31 32,500 32,500 Direct
2014-12-31 32,500 32,500 Direct
2014-05-16 7,500 7,500 Direct
Footnotes
  1. This constitutes the weighted average sale price. The prices range from $62.31 to $62.39. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. This constitutes the weighted average sale price. The prices range from $62.46 to $62.54. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  3. These securities are owned by Neal C. Bradsher, who is the Reporting Person.
  4. The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  5. Includes a restricted stock award of 4,183 shares granted to Neal C. Bradsher on May 24, 2013 under the Questcor Pharmaceuticals, Inc. (the "Company") 2006 Equity Incentive Award Plan, and that were inadvertently omitted from Form 4 filings made by Broadwood Partners, L.P. on June 17th, 2013 and November 13th, 2013. The shares will vest in full upon the earlier to occur of (i) May 24th, 2014 or (ii) the Company's 2014 Annual Shareholders' Meeting.
  6. These options are currently exercisable.
  7. Options granted under the Questcor Pharmaceuticals, Inc. 1992 Employee Stock Option Plan.
  8. These options vest in equal monthly installments over one year from the time of the grant.
  9. These options vest monthly over 48 months from the time of the grant.